We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Medtronic earnings rise, sales edge higher amid pressure from currency rates --Company highlights signs of stability in key markets, despite continued sales declines for some products --Full-year...
NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior...
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets NATICK, Mass. and LONDON, Nov. 20...
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets NATICK, Mass. and LONDON, Nov. 20...
House lawmakers will propose a $20 billion fee on medical device makers--chopping in half a $40 billion fee approved earlier this month by the Senate Finance Committee as part of a plan to pay for...
Boston Scientific Corp. (BSX) swung to a third-quarter gain following a charge-laden period last year, but sales grew less than Wall Street expected amid some softness in the market for...
Boston Scientific Corp. (BSX) swung to a third-quarter profit as the company recorded a small revenue increase and much smaller unusual charges. However, the medical-device maker lowered its...
(Updates stock price, adds analyst reaction beginning in 2nd paragraph.) By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) eked out a 1.1% increase in third-quarter profit, as...
(Adds details and background throughout, comments from J&J CFO beginning in seventh paragraph.) By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) eked out a 1.1% increase in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions